Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Altruist-new-product

More Like This

PR Newswire associated0

Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

PR Newswire associated0

Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site

PR Newswire associated0

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

PR Newswire associated0

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

Conformation-X Therapeutics Bolts out of Stealth, Securing Over $13.5M in Funding to Propel Its Innovative Immune-Oncology Pipeline

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates